Cost-effectiveness thresholds: the past, the present and the future
Cost-effectiveness (CE) thresholds are being discussed more frequently and there have
been many new developments in this area; however, there is a lack of understanding about …
been many new developments in this area; however, there is a lack of understanding about …
Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health …
A Pichon-Riviere, M Drummond, A Palacios… - The Lancet Global …, 2023 - thelancet.com
Background Assessment of the efficiency of interventions is paramount to achieving
equitable health-care systems. One key barrier to the widespread use of economic …
equitable health-care systems. One key barrier to the widespread use of economic …
[HTML][HTML] Resolving the “cost-effective but unaffordable” paradox: estimating the health opportunity costs of nonmarginal budget impacts
J Lomas, K Claxton, S Martin, M Soares - Value in Health, 2018 - Elsevier
Considering whether or not a proposed investment (an intervention, technology, or program
of care) is affordable is really asking whether the benefits it offers are greater than its …
of care) is affordable is really asking whether the benefits it offers are greater than its …
Avoiding opportunity cost neglect in cost-effectiveness analysis for health technology assessment
Despite being a fundamental tenet of economic analysis there is a lack of clarity regarding
the relevance of opportunity costs to cost-effectiveness analysis for health technology …
the relevance of opportunity costs to cost-effectiveness analysis for health technology …
[HTML][HTML] Estimating a cost-effectiveness threshold for healthcare decision-making in the Greek NHS
K Athanasakis, G Agorastos, I Kyriopoulos - Health Policy and Technology, 2024 - Elsevier
Background: The introduction of new health technologies leads to increases in well-being,
but also increases strains in the scarce resources of the health system. In this sense …
but also increases strains in the scarce resources of the health system. In this sense …
[PDF][PDF] Appraising ultra-orphan drugs: is cost-per-QALY appropriate? A review of the evidence
A Towse, M Garau - Consulting Report, 2018 - ohe.org
In April 2017, following a public consultation, NICE changed the method for appraising
drugs and other health technologies reviewed through its Highly Specialised Technology …
drugs and other health technologies reviewed through its Highly Specialised Technology …